E3Hyperlipidemia Treatment Guidelines. Flashcards
This deck addresses key points of the guidelines covering the management of dyslipidemia.
Per the 2017 AACE Guidelines for Management of dyslipidemia and prevention cardiovascular disease what are the goals of therapy?
To lower LDL
Per the 2017 AACE Guidelines for Management of dyslipidemia and prevention cardiovascular disease what are the cornerstone of therapy?
Statins are the corner stone of lipid lowering therapy to achieve optimal LDL levels.
Non-statin therapies are mentioned as adjunctive or alternative therapy.
What do the 2017 AACE guideline suggest using to assess ASCVD risk when cardiovascular risk is not clear?
Coronary Artery Calcium Score. (CAC)
What patients are considered extreme risk for ASCVD event?
- Progressive ASCVD after achieving LDL <70 mg/dL
- Established CVD with DM, CKD3/4, HeFH.
- History of premature ASCVD (<55 men, <65 women).
What patients are considered very high risk for ASCVD event?
- Established or recent hospitalization for ACS, coronary/carotid or PAD.
- Diabetes or CKD 3/4 with 1+ risk factor.
- HeFH
What are the goals for patients who are at extreme risk of ASCVD event?
<55 LDL
<80 Non-HDL-C
<70 APO B
What are the lipid panel goals for patients who are at very high risk for an ASCVD event?
LDL <70
NON-HDL-C <100
ApoB <80
Who is considered to be at high risk for an ASCVD event?
- 2+ risk factors and ASCVD 10-20%
- Diabetes or CKD 3/4 without other risk factors.
What is our total cholesterol goal for patients at risk for ASCVD disease?
<200 mg/dL
What are our LDL goals for the following risk groups?
Extreme, Very High, High, Moderate, Low
Extreme: <55
Very High: <70
High: <100 (same for moderate)
Low: <130
What is out TG goal for patients at risk for ASCVD disease?
<150 mg/dL
What are our ApoB goals for the following patients:
Extreme risk, very high risk, high risk.
Extreme: <70
Very High: <80
High: <90
